Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-02-22 09:24 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
37 - Stock split or consolidation
|
-17,142 vol |
2,858 | |
Filed 2024-02-22 09:23 Tx date 2023-10-11 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-171 vol |
29 | |
Filed 2023-11-08 15:33 Tx date 2023-10-30 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,000
+200,000 vol $0.05 each |
200,000 | |
Filed 2023-11-08 15:31 Tx date 2023-10-30 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
-50,000 vol |
0 | |
Filed 2023-07-21 18:26 Tx date 2023-07-20 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
50 - Grant of options
|
+20,000 vol |
20,000 | |
Filed 2023-07-21 18:25 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options Stock Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-05-24 20:00 Tx date 2023-05-23 |
$EDSA
Edesa Biotech, Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
200 | ||
Filed 2020-04-29 18:15 Tx date 2020-04-13 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,500
+50,000 vol $0.41 each |
50,000 | |
Filed 2020-04-07 15:18 Tx date 2020-04-06 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
0 | |
Filed 2020-04-07 15:17 Tx date 2020-04-06 |
$OVAT
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
+50,000 vol |
300,000 | |
Filed 2018-11-08 Tx date 2018-10-29 |
$
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,000 | ||
Filed 2018-11-08 Tx date 2018-10-29 |
$
Ovation Science Inc. |
Chypyha, Joan
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$302,906
+59,863 vol $5.06 each |
212,787 | |
Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
5,849 | |
Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
7,870 | |
Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
||
Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
||
Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+3,092 vol |
5,849 | |
Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-3,092 vol |
7,870 | |
Filed 2016-09-20 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.71
+183 vol $4.37 each |
2,757 | |
Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$801.00
+150 vol $5.34 each |
2,574 | |
Filed 2016-07-19 Tx date 2016-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.98
+134 vol $5.97 each |
2,424 | |
Filed 2016-06-20 Tx date 2016-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$803.03
+131 vol $6.13 each |
2,290 | |
Filed 2016-06-08 Tx date 2016-06-06 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-454 vol |
2,159 | |
Filed 2016-05-17 Tx date 2016-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.50
+123 vol $6.50 each |
2,613 | |
Filed 2016-04-20 Tx date 2016-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.68
+119 vol $6.72 each |
2,490 | |
Filed 2016-03-27 Tx date 2016-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-389 vol |
2,371 | |
Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+843 vol |
2,760 | |
Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-843 vol |
10,962 | |
Filed 2016-03-20 Tx date 2016-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$801.00
+150 vol $5.34 each |
1,917 | |
Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+9,275 vol |
11,805 | |
Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+9,275 vol |
11,805 | |
Filed 2016-03-02 Tx date 2016-02-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$172,628
+25,424 vol $6.79 each |
152,924 | |
Filed 2016-02-23 Tx date 2016-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$799.71
+183 vol $4.37 each |
1,767 | |
Filed 2016-01-21 Tx date 2016-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$397.80
+78 vol $5.10 each |
1,584 | |
Filed 2015-12-17 Tx date 2015-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$812.00
+175 vol $4.64 each |
1,506 | |
Filed 2015-11-20 Tx date 2015-11-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,197
+233 vol $5.14 each |
1,331 | |
Filed 2015-10-18 Tx date 2015-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,196
+253 vol $4.73 each |
1,098 | |
Filed 2015-09-18 Tx date 2015-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$797.50
+145 vol $5.50 each |
845 | |
Filed 2015-08-21 Tx date 2015-08-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$796.08
+93 vol $8.56 each |
700 | |
Filed 2015-07-20 Tx date 2015-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$798.98
+91 vol $8.78 each |
607 | |
Filed 2015-06-30 Tx date 2013-03-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+2,530 vol |
2,530 | |
Filed 2015-06-30 Tx date 2013-03-04 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2015-06-30 Tx date 2015-06-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+2,530 vol |
2,530 | |
Filed 2015-05-27 Tx date 2015-05-25 |
$CPH
Cipher Pharmaceuticals Inc. |
Chypyha, Joan
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$1,196
+115 vol $10.40 each |
516 |